CD274 and melanoma: In addition, studies on the expression of immune-related genes revealed that the expressions of CD274, PDCD1LG2, and TGFB1 are higher in high-glycolysis tumor cells than in low-glycolysis tumor cells (89), indicating that higher glycolysis of melanoma cells attenuates T cells by overexpressing these certain immune inhibitors (90).